ARCHIVES

GSK’s Pazopanib Benefits Similar to Sunitinib; Sponsor Points to More Favorable Safety Profile

This article is from The Cancer Letter archive.

Vol. 36 No. 8 | August 30, 2013

Download PDF Visit The Full Archive

Related Articles

NCI Taps Harlow To Head Office of Science Policy

July 26, 1996

55 NCI Grantees Win Shannon Awards, NCI gets $5.2 Mil.

October 4, 1991

Protection Commission Asks Hew To Adopt Entire Report As Policy for Human Subject Research

April 27, 1979

FDA Approves Evista for Breast Cancer Risk Reduction.

September 14, 2007

NCI To Sponsor Its Own Predoctoral Training At Some Institutions With Postdoctoral Awards

January 31, 1975

Klausner To Serve As Advisor On Bioterrorism For NAS.

January 4, 2002